1,1'-Carbonyldiimidazole → (2S)-3-Methyl-2-(2-oxo-1,4-dihydro-2H-quinazolin-3-yl)-butyric acid tert-butyl ester
Reaction equation
[C:1]([O:5][C:6](=[O:20])[C@@H:7]([NH:11][CH2:12][C:13]1[CH:18]=[CH:17][CH:16]=[CH:15][C:14]=1[NH2:19])[CH:8]([CH3:10])[CH3:9])([CH3:4])([CH3:3])[CH3:2].[C:21](N1C=CN=C1)(N1C=CN=C1)=[O:22]>C1COCC1>[C:1]([O:5][C:6](=[O:20])[C@@H:7]([N:11]1[CH2:12][C:13]2[C:14](=[CH:15][CH:16]=[CH:17][CH:18]=2)[NH:19][C:21]1=[O:22])[CH:8]([CH3:10])[CH3:9])([CH3:3])([CH3:4])[CH3:2]Participants
4
Procedure
To a solution of (2S)-2-(2-amino-benzylamino)-3-methyl-butyric acid tert-butyl ester (1.573 g, 5.65 mmol) in THF (20 mL) was added carbonyldiimidazol (1.008 g, 6.21 mmol) and the reaction was stirred under reflux overnight. The solvent was evaporated and the residue purified by flash chromatography (hexane/ethyl acetate, 50/50) to afford the sub-title compound as a yellow solid (662 mg, 38%). 1H NMR (400 MHz CDCl3) δ 0.95 (3H, d), 1.08 (3H, d), 1.49 (9H, s), 2.32 (1H, m), 4.39 (1H, d), 4.60 (1H, d), 4.72 (1H, d), 6.81 (1H, d), 6.94 (1H, t), 7.07 (1H, d), 7.18 (1H, t), 8.68 (1H, s).
Workup
- temperatureunder reflux overnight
- customThe solvent was evaporated
- customthe residue purified by flash chromatography (hexane/ethyl acetate, 50/50)
Sources & evidence
- ORD record
- ord-267b9084771a473d8c7d40a8b58c5631
- Source dataset
- uspto-grants-2012_01
- Patent number
- US08093392B2
Reaction notes
Loading…